Mraz Amerine & Associates’s PHX Minerals PHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,299
| Closed | -$57.2K | – | 196 |
|
|
2025
Q1 | $57.2K | Buy |
14,299
+10
| +0.1% | +$40 | 0.01% | 165 |
|
|
2024
Q4 | $57.2K | Sell |
14,289
-190
| -1% | -$698 | 0.01% | 162 |
|
|
2024
Q3 | $48.9K | Sell |
14,479
-65
| -0.4% | -$216 | 0.01% | 167 |
|
|
2024
Q2 | $47.4K | Hold |
14,544
| – | – | 0.01% | 167 |
|
|
2024
Q1 | $49.6K | Hold |
14,544
| – | – | 0.01% | 176 |
|
|
2023
Q4 | $46.8K | Buy |
14,544
+69
| +0.5% | +$237 | 0.01% | 174 |
|
|
2023
Q3 | $52.7K | Hold |
14,475
| – | – | 0.01% | 168 |
|
|
2023
Q2 | $45.2K | Sell |
14,475
-98
| -0.7% | -$279 | 0.01% | 175 |
|
|
2023
Q1 | $38.2K | Sell |
14,573
-95
| -0.6% | -$302 | 0.01% | 172 |
|
|
2022
Q4 | $57.1K | Sell |
14,668
-1,096
| -7% | -$4.11K | 0.01% | 167 |
|
|
2022
Q3 | $51K | Hold |
15,764
| – | – | 0.01% | 160 |
|
|
2022
Q2 | $48K | Buy |
15,764
+8
| +0.1% | +$28 | 0.01% | 166 |
|
|
2022
Q1 | $48K | Buy |
+15,756
| New | +$40.1K | 0.01% | 171 |
|
Mraz Amerine & Associates's PHX Position: Q2 2025 in Review
Mraz Amerine & Associates sold out of PHX Minerals (PHX) in Q2 2025, closing a stake of 14,299 shares — an estimated $57.2K sold.
Mraz Amerine & Associates first reported a position in PHX in Q1 2022 and held it in 13 quarters. The position peaked at $57.2K in Q1 2025. 0 funds tracked by Wall St. Rank hold PHX as of Q2 2025.
- Mraz Amerine & Associates reported no remaining PHX Minerals position as of Q2 2025 after selling out during the quarter.
- Mraz Amerine & Associates sold 14,299 PHX Minerals shares in Q2 2025, an estimated $57.2K.
- Mraz Amerine & Associates first reported a position in PHX Minerals in Q1 2022 and held it in 13 quarters.
- Mraz Amerine & Associates's PHX Minerals position peaked at $57.2K in Q1 2025.
- 0 funds tracked by Wall St. Rank held PHX Minerals as of Q2 2025.
Based on Mraz Amerine & Associates's 13F filing for Q2 2025, filed 23 Jul 2025.